What is the current valuation of the US pharmaceutical isolator market?

The market valuation was $2100.0 Million in 2024. Read More

What is the projected market size for the US pharmaceutical isolator market by 2035?

The market is projected to reach $5900.0 Million by 2035. Read More

What is the expected CAGR for the US pharmaceutical isolator market during the forecast period 2025 - 2035?

The expected CAGR is 9.85% during the forecast period. Read More

Which companies are considered key players in the US pharmaceutical isolator market?

Key players include Sartorius, Getinge, Thermo Fisher Scientific, and Merck KGaA. Read More

What are the main types of pharmaceutical isolators available in the market?

The main types are Open Isolators and Closed Isolators, valued at $840.0 Million and $1260.0 Million respectively. Read More

What product types are included in the US pharmaceutical isolator market?

Product types include Sterility Test Isolators, Process Isolators, and Decontamination Pass Boxes. Read More

What is the market valuation for ISO Class 5 pharmaceutical isolators?

ISO Class 5 isolators are valued at $1260.0 Million. Read More

Which applications are driving demand in the US pharmaceutical isolator market?

Applications include Sterility Testing, Sampling/Weighing/Distribution, and Aseptic Tissue Handling. Read More

What end-user segments are prominent in the US pharmaceutical isolator market?

Prominent end-users include BioPharma/Cell & Gene therapy Companies and Academic & Research Institutes. Read More

How does the market performance of Closed Isolators compare to Open Isolators?

Closed Isolators show a higher valuation at $1260.0 Million compared to Open Isolators at $840.0 Million. Read More

US Pharmaceutical Isolator Market

ID: MRFR/Pharma/18464-HCR

100 Pages

Satyendra Maurya

Last Updated: April 24, 2026

US Pharmaceutical Isolator Market Research Report: Size, Share, Trend Analysis By Product Type (Open Isolator, Closed Isolator), By Product Type (Sterility Test Isolator, Process Isolator, Decontamination Pass Box), By Product Class (ISO Class 3, ISO Class 5), By Applications (Sterility Testing, Sampling/ Weighing/ Distribution, Animal Laboratories, Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling, Defiltration and Drying, Others) and By End Users (BioPharma/Cell & Gene therapy Companies, Academic & Research Institutes, Hospitals, Contract Research Organization & Contract Manufacturing Organization) - Growth Outlook & Industry Forecast 2025 To 2035

English

US Pharmaceutical Isolator Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Open Isolator
  2. 4.1.2 Closed Isolator
2. 4.2 Chemicals and Materials, BY Product Type (USD Million)
  1. 4.2.1 Sterility Test Isolator
  2. 4.2.2 Process Isolator
  3. 4.2.3 Decontamination Pass Box
3. 4.3 Chemicals and Materials, BY Product Class (USD Million)
  1. 4.3.1 ISO Class 3
  2. 4.3.2 ISO Class 5
4. 4.4 Chemicals and Materials, BY Application (USD Million)
  1. 4.4.1 Sterility Testing
  2. 4.4.2 Sampling/ Weighing/ Distribution
  3. 4.4.3 Animal Laboratories
  4. 4.4.4 Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling
  5. 4.4.5 Defiltration and Drying
  6. 4.4.6 Others
5. 4.5 Chemicals and Materials, BY End User (USD Million)
  1. 4.5.1 BioPharma/Cell & Gene therapy Companies
  2. 4.5.2 Academic & Research Institutes
  3. 4.5.3 Hospitals
  4. 4.5.4 Contract Research Organization & Contract Manufacturing Organization
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Sartorius (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Getinge (SE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Eppendorf (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Aseptic Technologies (BE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fedegari (IT)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cytiva (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Baker (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 US MARKET ANALYSIS BY PRODUCT CLASS
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
13. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
17. 6.17 CHEMICALS AND MATERIALS, BY PRODUCT CLASS, 2024 (% SHARE)
18. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT CLASS, 2024 TO 2035 (USD Million)
19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
20. 6.20 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
21. 6.21 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
22. 6.22 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY PRODUCT CLASS, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Type (USD Million, 2025-2035)

Open Isolator
Closed Isolator

Chemicals and Materials By Product Type (USD Million, 2025-2035)

Sterility Test Isolator
Process Isolator
Decontamination Pass Box

Chemicals and Materials By Product Class (USD Million, 2025-2035)

ISO Class 3
ISO Class 5

Chemicals and Materials By Application (USD Million, 2025-2035)

Sterility Testing
Sampling/ Weighing/ Distribution
Animal Laboratories
Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling
Defiltration and Drying
Others

Chemicals and Materials By End User (USD Million, 2025-2035)

BioPharma/Cell & Gene therapy Companies
Academic & Research Institutes
Hospitals
Contract Research Organization & Contract Manufacturing Organization

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”